View in EDS

Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial.

Saved in:
Bibliographic Details
Title: Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial.
Authors: Jenkin D; Jenner Institute, University of Oxford, Oxford, UK; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, University of Oxford, Oxford, UK., Ritchie AJ; Jenner Institute, University of Oxford, Oxford, UK., Aboagye J; Jenner Institute, University of Oxford, Oxford, UK., Fedosyuk S; Jenner Institute, University of Oxford, Oxford, UK., Thorley L; Jenner Institute, University of Oxford, Oxford, UK., Provstgaad-Morys S; Jenner Institute, University of Oxford, Oxford, UK., Sanders H; Jenner Institute, University of Oxford, Oxford, UK., Bellamy D; Jenner Institute, University of Oxford, Oxford, UK., Makinson R; Jenner Institute, University of Oxford, Oxford, UK., Xiang ZQ; Wistar Institute of Anatomy & Biology, Philadelphia, PA, USA., Bolam E; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK., Tarrant R; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK., Ramos Lopez F; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, University of Oxford, Oxford, UK., Platt A; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, University of Oxford, Oxford, UK., Poulton I; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, University of Oxford, Oxford, UK., Green C; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK., Ertl HCJ; Wistar Institute of Anatomy & Biology, Philadelphia, PA, USA., Ewer KJ; Jenner Institute, University of Oxford, Oxford, UK., Douglas AD; Jenner Institute, University of Oxford, Oxford, UK. Electronic address: sandy.douglas@ndm.ox.ac.uk.
Source: The Lancet. Microbe [Lancet Microbe] 2022 Sep; Vol. 3 (9), pp. e663-e671. Date of Electronic Publication: 2022 Jul 27.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-5247 (Electronic) Linking ISSN: 26665247 NLM ISO Abbreviation: Lancet Microbe Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35907430
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jenkin+D%22">Jenkin D</searchLink>; Jenner Institute, University of Oxford, Oxford, UK; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Ritchie+AJ%22">Ritchie AJ</searchLink>; Jenner Institute, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Aboagye+J%22">Aboagye J</searchLink>; Jenner Institute, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Fedosyuk+S%22">Fedosyuk S</searchLink>; Jenner Institute, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Thorley+L%22">Thorley L</searchLink>; Jenner Institute, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Provstgaad-Morys+S%22">Provstgaad-Morys S</searchLink>; Jenner Institute, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Sanders+H%22">Sanders H</searchLink>; Jenner Institute, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Bellamy+D%22">Bellamy D</searchLink>; Jenner Institute, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Makinson+R%22">Makinson R</searchLink>; Jenner Institute, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Xiang+ZQ%22">Xiang ZQ</searchLink>; Wistar Institute of Anatomy & Biology, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Bolam+E%22">Bolam E</searchLink>; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Tarrant+R%22">Tarrant R</searchLink>; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Ramos+Lopez+F%22">Ramos Lopez F</searchLink>; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Platt+A%22">Platt A</searchLink>; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Poulton+I%22">Poulton I</searchLink>; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Green+C%22">Green C</searchLink>; Clinical Biomanufacturing Facility, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Ertl+HCJ%22">Ertl HCJ</searchLink>; Wistar Institute of Anatomy & Biology, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Ewer+KJ%22">Ewer KJ</searchLink>; Jenner Institute, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Douglas+AD%22">Douglas AD</searchLink>; Jenner Institute, University of Oxford, Oxford, UK. Electronic address: sandy.douglas@ndm.ox.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101769019%22">The Lancet. Microbe</searchLink> [Lancet Microbe] 2022 Sep; Vol. 3 (9), pp. e663-e671. <i>Date of Electronic Publication: </i>2022 Jul 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101769019 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-5247 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226665247%22">26665247 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Microbe <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35907430
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S2666-5247(22)00126-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e663
    Titles:
      – TitleFull: Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jenkin D
      – PersonEntity:
          Name:
            NameFull: Ritchie AJ
      – PersonEntity:
          Name:
            NameFull: Aboagye J
      – PersonEntity:
          Name:
            NameFull: Fedosyuk S
      – PersonEntity:
          Name:
            NameFull: Thorley L
      – PersonEntity:
          Name:
            NameFull: Provstgaad-Morys S
      – PersonEntity:
          Name:
            NameFull: Sanders H
      – PersonEntity:
          Name:
            NameFull: Bellamy D
      – PersonEntity:
          Name:
            NameFull: Makinson R
      – PersonEntity:
          Name:
            NameFull: Xiang ZQ
      – PersonEntity:
          Name:
            NameFull: Bolam E
      – PersonEntity:
          Name:
            NameFull: Tarrant R
      – PersonEntity:
          Name:
            NameFull: Ramos Lopez F
      – PersonEntity:
          Name:
            NameFull: Platt A
      – PersonEntity:
          Name:
            NameFull: Poulton I
      – PersonEntity:
          Name:
            NameFull: Green C
      – PersonEntity:
          Name:
            NameFull: Ertl HCJ
      – PersonEntity:
          Name:
            NameFull: Ewer KJ
      – PersonEntity:
          Name:
            NameFull: Douglas AD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2022 Sep
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2666-5247
          Numbering:
            – Type: volume
              Value: 3
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: The Lancet. Microbe
              Type: main
ResultId 1